Cyclophosphamide for GVHD Continues to Extend Stem-Cell Transplant Eligibility

(MedPage Today) — Patients who underwent stem cell transplants (SCTs) involving mismatched unrelated donors (MMUDs) had a 1-year overall survival (OS) of about 80% with post-transplant cyclophosphamide (PTCy)-based prophylaxis for graft-versus…

Source link : https://www.medpagetoday.com/hematologyoncology/hematology/116263

Author :

Publish date : 2025-06-26 16:04:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30

Cyclophosphamide for GVHD Continues to Extend Stem-Cell Transplant Eligibility

Make America Fit Again

$2M Award in Decapitated Baby Case; Doc Accused of Removing Fentanyl From IV Line

Related Posts

Kennedy’s ACIP Backs Monoclonal Antibody for RSV Prevention in Infants

New-Look ACIP Votes No to Flu Vaccines With Thimerosal

Oklahoma Applies for SNAP Waiver to Bar Payment for Sodas, Candy, Baked Goods

SAVR With Root Enlargement Crucial for Women With Small Annuli

Medtronic Recall After 33 Injuries; Private Equity in Gastroenterology; MASLD Crisis

TriClip Raises Standing of Single-Session Mitral and Tricuspid TEER

Kennedy’s ACIP Backs Monoclonal Antibody for RSV Prevention in Infants

New-Look ACIP Votes No to Flu Vaccines With Thimerosal

Oklahoma Applies for SNAP Waiver to Bar Payment for Sodas, Candy, Baked Goods

SAVR With Root Enlargement Crucial for Women With Small Annuli

Medtronic Recall After 33 Injuries; Private Equity in Gastroenterology; MASLD Crisis

TriClip Raises Standing of Single-Session Mitral and Tricuspid TEER

Ash trees are rapidly evolving some resistance to ash dieback disease

‘These Doctors Should Lose Their Licenses’; Public Health Eras Tour; MD’s Abortion

Categories

Archives